Brisk Walking Study in Nursing Home Residents

NCT ID: NCT03302923

Last Updated: 2018-05-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-06-01

Study Completion Date

2019-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is well established that physical activity reduces the physiological effects of ageing. Among them, the decrease of the autonomic nervous system activity (ANS) is associated with the increase of cardiovascular events and sleep disorders occurence. It has been shown that high intensity cycle training can enhance the ANS activity by 30% in people aged of 70 years old. However, such trainings were done by old athletes used to train at intensities that could not be handled by nursing home elderly. Thus, an adapted activity such as brisk walking shall be defined to make it practicable for the many in convalescent homes. The investigators hypothesize that long term brisk walking training could lead to reactivate ANS in people living in convalescent homes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators aim to compare the effects of a 9 month brisk walking training (1 time a week or 3 times a week) on the ANS of nursing home residents.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Physical Activity Autonomic Nervous System Imbalance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Brisk walking 1

1 time a week of 9 months brisk walking

Group Type EXPERIMENTAL

Brisk walking

Intervention Type BEHAVIORAL

Prospective randomized clinical trial with 2 intervention groups and 1 control group.

Brisk walking 3

3 times a week of 9 months brisk walking

Group Type EXPERIMENTAL

Brisk walking

Intervention Type BEHAVIORAL

Prospective randomized clinical trial with 2 intervention groups and 1 control group.

Control group

No brisk walking session

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Brisk walking

Prospective randomized clinical trial with 2 intervention groups and 1 control group.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being over 60 years old
* Living in a nursing home of Mutualité Française de la Loire, France
* Being able to walk without human aid
* Being able to speak and write French
* Being inactive (less than 1 hours of physical activity per week)
* Having a normal sinus rhythm
* Being affiliated to the social welfare system
* Signing the informed consent form

Exclusion Criteria

* Having serious balance disorders
* Suffering from cardiac or respiratory pathologies that contraindicate physical activity
* Serious comorbidities contraindicating physical activity
* Diagnosed cardiac pathologies that prevent heart rate variability analysis: congestive heart failure, cardiac pacemaker, implantable cardioverter defibrillator, serious ventricular rhythm troubles, atrial fibrillation, atrial flutter.
* Persons under legal protection
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital of Saint-Etienne

OTHER

Sponsor Role collaborator

University of Lyon

OTHER

Sponsor Role collaborator

Clinique Mutualiste Chirurgicale de la Loire

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David HUPIN, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University Hospital of Saint-Etienne

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

French Loire Mutuality

Saint-Etienne, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

David HUPIN, MD, PhD

Role: CONTACT

0477829109 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Claude MONTUY-COQUARD, Me

Role: primary

0477476309 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016-A00068-43

Identifier Type: REGISTRY

Identifier Source: secondary_id

2016-08

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Measuring Outcomes of Activity in Intensive Care
NCT03115840 ACTIVE_NOT_RECRUITING